Pure Global: EU MedTech's EUDAMED Deadline & Its Hidden Risks

The clock is ticking on a major regulatory shift in the European Union. With the mandatory use of key EUDAMED modules fast approaching, the era of radical transparency for medical devices is here. This isn't just a compliance update; it's a fundamental change that exposes manufacturers to new levels of public and competitor scrutiny, where every piece of data is visible to the world. This episode of MedTech Global Insights unpacks the hidden risks and strategic challenges of the EUDAMED transition. We go beyond the administrative checklist to explore how this new database could become a source of litigation, a tool for your competitors, and a major test of your company's data integrity. We discuss the practical steps you need to take now to protect your market presence. For instance, imagine your company just discovered a minor discrepancy in the clinical data submitted years ago for the same device in Spain versus Germany. Before, this was a manageable local issue. In the world of EUDAMED, this is now a public contradiction that can be seen by regulators, competitors, and customers across the EU, potentially halting your sales. 本期干货 1. What are the key EUDAMED modules that just became mandatory and what do they require? 2. How does public data access change your competitive landscape in Europe? 3. What are the top three data discrepancies that could put your device at risk in EUDAMED? 4. Why is your old approach to managing technical files no longer viable? 5. Beyond compliance, how can you leverage EUDAMED as a tool to build market trust? 6. Is your post-market surveillance data truly ready for public scrutiny? 7. What are the legal risks associated with incorrect or inconsistent data entries? 8. How does this impact startups and scale-ups differently than multinational enterprises? Contact us at [e-mail] or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.